ADVANCED COLORECTAL ADENOCARCINOMA
Clinical trials for ADVANCED COLORECTAL ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new ADVANCED COLORECTAL ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for ADVANCED COLORECTAL ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo aims to outperform standard therapy for advanced colorectal cancer
Disease control Not yet recruitingThis phase 3 trial tests whether adding the experimental drug SHR-A1811 to standard chemotherapy and bevacizumab works better than standard therapy alone for people with advanced colorectal cancer who have not had prior treatment. About 300 participants will receive either the ne…
Matched conditions: ADVANCED COLORECTAL ADENOCARCINOMA
Phase: PHASE3 • Sponsor: Suzhou Suncadia Biopharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Cottonseed compound plus immunotherapy takes on tough colorectal cancer
Disease control Not yet recruitingThis phase 2 trial tests whether combining sintilimab (an immunotherapy) with gossypol acetate (a compound from cottonseed) can shrink tumors in people with advanced colorectal cancer that has not responded to at least two prior treatments. The study will enroll 32 adults aged 18…
Matched conditions: ADVANCED COLORECTAL ADENOCARCINOMA
Phase: PHASE2 • Sponsor: Peking University People's Hospital • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New drug cocktail hopes to tackle advanced colon cancer
Disease control Not yet recruitingThis study tests a new drug called HDM2017 combined with standard treatment (fruquintinib) in 120 people with advanced colorectal cancer that has spread. The goal is to find the safest dose and see if the combination can shrink tumors. Participants must have tried other treatment…
Matched conditions: ADVANCED COLORECTAL ADENOCARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Donor cells join fight against advanced cancers
Disease control Not yet recruitingThis early study tests whether adding donor natural killer (NK) cells to standard maintenance therapy can safely help control advanced lung and colorectal cancers. About 20 adults will receive NK cell infusions alongside their usual drugs. The main goal is to check for side effec…
Matched conditions: ADVANCED COLORECTAL ADENOCARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: BOE Technology Group Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
New hope for advanced colon cancer: experimental combo enters phase 2 trial
Disease control Not yet recruitingThis study tests a new drug called AMT-676 combined with standard chemotherapy and targeted therapy for people with advanced colorectal cancer that cannot be removed by surgery. The goal is to see if the combination is safe and helps shrink tumors or slow the disease. About 180 a…
Matched conditions: ADVANCED COLORECTAL ADENOCARCINOMA
Phase: PHASE2 • Sponsor: Multitude Therapeutics Inc. • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC